Celcuity Financial Statements
NASDAQ: CELCHealth CareMedical SpecialitiesUSD
67.87+2.09 (+3.18%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Celcuity revenue and earnings
Celcuity reported a net loss of $177.0 million, compared with a loss of $111.8 million a year earlier. Diluted earnings per share came in at -$3.79.
Summary generated from market data by MetaCap's automated system. Methodology
Celcuity income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 172.19M | 113.27M | 66.23M | 39.39M | 28.36M | 9.56M | 7.81M | 7.93M | 5.95M | 3.33M |
| Research & Development | 145.00M | 104.20M | 60.59M | 35.29M | 25.76M | 7.68M | 6.27M | 6.33M | 4.98M | 3.06M |
| Operating Income | -172.19M | -113.27M | -66.23M | -39.39M | -28.36M | -9.56M | -7.81M | -7.93M | -5.95M | -3.33M |
| Interest Expense | 17.15M | 10.28M | 5.33M | 2.11M | 1.26M | 120 | 159 | 111 | 451.66K | 0 |
| Other Income (Expense) | -4.85M | 1.49M | 2.45M | -978.95K | -1.25M | 81.99K | 445.94K | 451.72K | -298.79K | 18.02K |
| Pretax Income | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M | -9.47M | -7.36M | -7.48M | -6.25M | -3.31M |
| Income Tax | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
| Net Income | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M | -9.47M | -7.36M | -7.48M | -6.25M | -3.31M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 | -0.74 | -0.84 | -0.52 |
| EPS (Diluted) | -3.79 | -2.83 | -2.69 | -2.64 | -2.21 | -0.92 | -0.72 | -0.74 | -0.84 | -0.52 |
| Shares Outstanding (Basic) | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M | 10.27M | 10.23M | 10.12M | 7.46M | 6.31M |
| Shares Outstanding (Diluted) | 46.76M | 39.45M | 23.68M | 15.42M | 13.38M | 10.27M | 10.23M | 10.12M | 7.46M | 6.31M |
| EBITDA | -172.03M | -113.14M | -66.09M | -39.18M | -28.05M | -9.17M | -7.47M | -7.71M | -5.85M | -3.26M |
This table shows 10 annual periods of Celcuity's income statement, from FY 2025 back to FY 2016, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow CELC's reporting calendar. What is a income statement?